GENE ONLINE|News &
Opinion
Blog

Drug Approval
Santhera, ReveraGen’s Duchenne Drug Accepted By EMA While Anticipating FDA Priority Review
2022-11-01
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Mounting Criticisms of FDA’s Accelerated Approval Pathway Could Prompt Changes to the System
2022-08-25
Three Previously Approved Treatments Show Anti-monkeypox Activity
2022-08-08
Everest Medicines Secures Breast Cancer Drug Approval in China
2022-06-13
WSJ Health Forum 2022: Psychedelics Set to Take Center Stage in Mental Wellness
2022-03-24
FDA Approves Drug for Schizophrenia in Pediatric Patients
2022-01-10
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
FDA Greenlights Blueprint Medicines’ Ayvakit for Rare Disease Treatment
2021-06-21
Novartis Wins Five Simultaneous Drug Approvals in Japan
2020-07-06
LATEST
Advancements in Alzheimer’s Disease Drug Innovation and Funding Programs in 2024
2024-07-04
FDA Greenlights Eli Lilly’s Groundbreaking Alzheimer’s Drug Kisunla for Early Symptomatic Treatment
2024-07-04
BIO Asia–Taiwan 2024 Set to Showcase Global Biotech Industry Talent on July 24th
2024-07-03
Novo Nordisk’s CLARION-CKD Trial Shut Down After Unsuccessful Results Causing Impairment Loss
2024-07-03
Tanvex BioPharma Secures Asia’s First FDA Approval for Filgrastim Biosimilar, Seizing a $403 Million Market
2024-07-03
Ginkgo Job Cuts Expected to Affect at Least 35% of Workforce, Eliminating Over 400 Jobs
2024-07-02
Eli Lilly and OpenAI Team Up to Combat Drug-Resistant Pathogens
2024-07-02
EVENT
Scroll to Top